4-190027044-T-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 0P and 2B. BP4_Moderate
The NM_001286820.2(FRG2):c.161A>C(p.Lys54Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001286820.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00 AC: 4AN: 95130Hom.: 1 Cov.: 15 FAILED QC
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.00000819 AC: 11AN: 1343636Hom.: 1 Cov.: 29 AF XY: 0.00000448 AC XY: 3AN XY: 669404
GnomAD4 genome Data not reliable, filtered out with message: AS_VQSR AF: 0.0000420 AC: 4AN: 95130Hom.: 1 Cov.: 15 AF XY: 0.0000436 AC XY: 2AN XY: 45886
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.161A>C (p.K54T) alteration is located in exon 1 (coding exon 1) of the FRG2 gene. This alteration results from a A to C substitution at nucleotide position 161, causing the lysine (K) at amino acid position 54 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at